RecruitingNot ApplicableNCT06402643

Comparison of Recurrence Between Mini-SLET and Limbal-Conjunctival Autograft Techniques in Primary Pterygium

Comparative Analysis of Recurrence Rate Between Mini-Slet (Simple Limbal Epithelial Transplantation) Versus Limbal-Conjunctival Autograft Techniques in Primary Pterygium Excision


Sponsor

Instituto de Oftalmología Fundación Conde de Valenciana

Enrollment

68 participants

Start Date

Jun 22, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The surgical treatment options for pterygium, an abnormal growth on the eye's frontal surface can be treated with several surgical techniques. The rates of pterygium coming back varies depending on the surgical technique employed and other factors related to the patient and surgery. The objective of this study is to assess the efficacy and safety of incorporating a single amniotic membrane with stem cells in the treatment of primary pterygium, aiming to enhance surgical outcomes and minimize recurrence rates.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients with primary nasal pterygium > 2mm
  • Patients who can present and continue follow-up for the duration of the study
  • Acceptance to participate in the study by signing the informed consent.

Exclusion Criteria6

  • Patients with rheumatoid arthritis
  • Collagenopathy
  • Pregnant
  • Infection, conjunctival inflammation or ocular trauma
  • Glaucoma
  • Previous ocular surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPterygium Excision

Pterygium will be surgically removed utilizing conventional resection techniques, entailing a blunt resection of the head, neck, and body of the pterygium. Subsequent to the resection, the surgical site will be polished using a surgical diamond burr if deemed necessary, and hemostasis will be achieved using bipolar cautery.


Locations(1)

Instituto de oftalmología conde de Valenciana

Mexico City, Mexico

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06402643


Related Trials